Obesity and Breast Cancer: The Role of Dysregulated Estrogen Metabolism (SpringerBriefs in Cancer Research)

0 valoración promedio
( 0 valoraciones por Goodreads )
 
9781489980014: Obesity and Breast Cancer: The Role of Dysregulated Estrogen Metabolism (SpringerBriefs in Cancer Research)

Obesity is a risk factor for breast cancer in older women. A number of adipose-derived and obesity-related factors have been shown to affect tumour cell growth. These include adipokines, insulin, IGF-1 and oestrogens. The majority of obesity-related postmenopausal breast cancers are oestrogen-dependent. Since the ovaries no longer produce oestrogens after menopause, and that circulating levels are negligible, it is evident that it is the oestrogens produced locally within the breast adipose that are responsible for the increased growth of breast cancer cells. Aromatase is the enzyme that converts androgens into oestrogens and its regulation is dependent on the activity of a number of tissue-specific promoters. Targeting oestrogen biosynthesis in obesity may be useful for the prevention of breast cancer. Aromatase inhibitors are efficacious at treating postmenopausal breast cancer and recent studies suggest that they may also be useful in the prevention setting. However, these compounds inhibit the catalytic activity of aromatase and as a consequence lead to a number of undesirable side-effects, including arthralgia and possible cognitive defects due to inhibition of aromatase in the bone and brain, respectively. Novel therapies, such as those employed to treat obesity-associated disease, including anti-diabetics, may prove successful at inhibiting aromatase specifically within the breast. This SpringerBrief will explore all of these issues in depth and the authors are in a unique position to write about this topic, having extensive experience in the field of aromatase research.

"Sinopsis" puede pertenecer a otra edición de este libro.

About the Author:

Kristy A. Brown, Ph.D., is a NHMRC Career Development Fellow and Co-Head of the Metabolism and Cancer Group at Prince Henry's Institute. Dr. Brown is also an Adjunct Lecturer of Physiology at Monash University. Dr Brown's area of research interest is the regulation of the aromatase gene in the context of obesity and breast cancer.

Evan Simpson, Ph.D., is a Senior Principal Research Fellow and Co-Head of the Metabolism and Cancer group at Prince Henry's Institute. He is also an Honorary Professor for the Department of Biochemistry and Molecular Biology and Monash University. Dr. Simpson is the Laboratory Director of the Victorian Breast Cancer Research Consortium. This consortium involves eight medical research institutes and was established in 1997 to conduct world class research into breast cancer. Dr. Simpson's work also led to the creation of the first aromatase knockout (ArKO) mouse, which is a model of oestrogen insufficiency that compares with the phenotype of humans with natural mutations in aromatase. His current research is focused on the role of oestrogen in several important health conditions, including obesity, diabetes, osteoporosis and of course, breast cancer.

"Sobre este título" puede pertenecer a otra edición de este libro.

Comprar nuevo Ver libro

Gastos de envío: EUR 4,37
De Reino Unido a Estados Unidos de America

Destinos, gastos y plazos de envío

Añadir al carrito

Los mejores resultados en AbeBooks

1.

Brown, Kristy A.
Editorial: Springer (2016)
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos Paperback Cantidad: 1
Impresión bajo demanda
Librería
Ria Christie Collections
(Uxbridge, Reino Unido)
Valoración
[?]

Descripción Springer, 2016. Paperback. Estado de conservación: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Nº de ref. de la librería ria9781489980014_lsuk

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 55,02
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 4,37
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

2.

Brown, Kristy A.
Editorial: Springer-Verlag New York Inc. (2013)
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos Cantidad: > 20
Impresión bajo demanda
Librería
Pbshop
(Wood Dale, IL, Estados Unidos de America)
Valoración
[?]

Descripción Springer-Verlag New York Inc., 2013. PAP. Estado de conservación: New. New Book.Shipped from US within 10 to 14 business days.THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Nº de ref. de la librería IP-9781489980014

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 57,54
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,40
A Estados Unidos de America
Destinos, gastos y plazos de envío

3.

K. A. Brown, Evan Simpson
Editorial: Springer-Verlag New York Inc., United States (2013)
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos Paperback Cantidad: 1
Librería
The Book Depository US
(London, Reino Unido)
Valoración
[?]

Descripción Springer-Verlag New York Inc., United States, 2013. Paperback. Estado de conservación: New. 2014 ed.. Language: English . Brand New Book. Obesity is a risk factor for breast cancer in older women. A number of adipose-derived and obesity-related factors have been shown to affect tumour cell growth. These include adipokines, insulin, IGF-1 and oestrogens. The majority of obesity-related postmenopausal breast cancers are oestrogen-dependent. Since the ovaries no longer produce oestrogens after menopause, and that circulating levels are negligible, it is evident that it is the oestrogens produced locally within the breast adipose that are responsible for the increased growth of breast cancer cells. Aromatase is the enzyme that converts androgens into oestrogens and its regulation is dependent on the activity of a number of tissue-specific promoters. Targeting oestrogen biosynthesis in obesity may be useful for the prevention of breast cancer. Aromatase inhibitors are efficacious at treating postmenopausal breast cancer and recent studies suggest that they may also be useful in the prevention setting. However, these compounds inhibit the catalytic activity of aromatase and as a consequence lead to a number of undesirable side-effects, including arthralgia and possible cognitive defects due to inhibition of aromatase in the bone and brain, respectively. Novel therapies, such as those employed to treat obesity-associated disease, including anti-diabetics, may prove successful at inhibiting aromatase specifically within the breast. This SpringerBrief will explore all of these issues in depth and the authors are in a unique position to write about this topic, having extensive experience in the field of aromatase research.â. Nº de ref. de la librería LIB9781489980014

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 62,10
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

4.

K. A. Brown, Evan Simpson
Editorial: Springer-Verlag New York Inc., United States (2013)
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos Paperback Cantidad: 1
Librería
The Book Depository
(London, Reino Unido)
Valoración
[?]

Descripción Springer-Verlag New York Inc., United States, 2013. Paperback. Estado de conservación: New. 2014 ed.. Language: English . Brand New Book. Obesity is a risk factor for breast cancer in older women. A number of adipose-derived and obesity-related factors have been shown to affect tumour cell growth. These include adipokines, insulin, IGF-1 and oestrogens. The majority of obesity-related postmenopausal breast cancers are oestrogen-dependent. Since the ovaries no longer produce oestrogens after menopause, and that circulating levels are negligible, it is evident that it is the oestrogens produced locally within the breast adipose that are responsible for the increased growth of breast cancer cells. Aromatase is the enzyme that converts androgens into oestrogens and its regulation is dependent on the activity of a number of tissue-specific promoters. Targeting oestrogen biosynthesis in obesity may be useful for the prevention of breast cancer. Aromatase inhibitors are efficacious at treating postmenopausal breast cancer and recent studies suggest that they may also be useful in the prevention setting. However, these compounds inhibit the catalytic activity of aromatase and as a consequence lead to a number of undesirable side-effects, including arthralgia and possible cognitive defects due to inhibition of aromatase in the bone and brain, respectively. Novel therapies, such as those employed to treat obesity-associated disease, including anti-diabetics, may prove successful at inhibiting aromatase specifically within the breast. This SpringerBrief will explore all of these issues in depth and the authors are in a unique position to write about this topic, having extensive experience in the field of aromatase research.â. Nº de ref. de la librería LIB9781489980014

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 62,23
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

5.

Evan R. Simpson
Editorial: Springer-Verlag New York Inc.
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos Paperback Cantidad: > 20
Librería
BuySomeBooks
(Las Vegas, NV, Estados Unidos de America)
Valoración
[?]

Descripción Springer-Verlag New York Inc. Paperback. Estado de conservación: New. Paperback. 55 pages. Obesity is a risk factor for breast cancer in older women. A number of adipose-derived and obesity-related factors have been shown to affect tumour cell growth. These include adipokines, insulin, IGF-1 and oestrogens. The majority of obesity-related postmenopausal breast cancers are oestrogen-dependent. Since the ovaries no longer produce oestrogens after menopause, and that circulating levels are negligible, it is evident that it is the oestrogens produced locally within the breast adipose that are responsible for the increased growth of breast cancer cells. Aromatase is the enzyme that converts androgens into oestrogens and its regulation is dependent on the activity of a number of tissue-specific promoters. Targeting oestrogen biosynthesis in obesity may be useful for the prevention of breast cancer. Aromatase inhibitors are efficacious at treating postmenopausal breast cancer and recent studies suggest that they may also be useful in the prevention setting. However, these compounds inhibit the catalytic activity of aromatase and as a consequence lead to a number of undesirable side-effects, including arthralgia and possible cognitive defects due to inhibition of aromatase in the bone and brain, respectively. Novel therapies, such as those employed to treat obesity-associated disease, including anti-diabetics, may prove successful at inhibiting aromatase specifically within the breast. This SpringerBrief will explore all of these issues in depth and the authorsare in a unique position to write about this topic, havingextensive experience in the field of aromatase research. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Paperback. Nº de ref. de la librería 9781489980014

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 63,68
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

6.

Brown, Kristy A.
Editorial: Springer-Verlag New York Inc. (2013)
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos Cantidad: > 20
Impresión bajo demanda
Librería
Books2Anywhere
(Fairford, GLOS, Reino Unido)
Valoración
[?]

Descripción Springer-Verlag New York Inc., 2013. PAP. Estado de conservación: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. Nº de ref. de la librería IP-9781489980014

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 57,91
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 10,16
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

7.

KRISTY A. BROWN
Editorial: Springer (2013)
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos Paperback Cantidad: 1
Librería
Herb Tandree Philosophy Books
(Stroud, GLOS, Reino Unido)
Valoración
[?]

Descripción Springer, 2013. Paperback. Estado de conservación: NEW. 9781489980014 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Nº de ref. de la librería HTANDREE0408635

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 63,92
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 9,03
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

8.

Kristy A. Brown, Evan R. Simpson
Editorial: Springer New York 2013-11-21, New York (2013)
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos paperback Cantidad: > 20
Librería
Blackwell's
(Oxford, OX, Reino Unido)
Valoración
[?]

Descripción Springer New York 2013-11-21, New York, 2013. paperback. Estado de conservación: New. Nº de ref. de la librería 9781489980014

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 67,40
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,77
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

9.

Kristy A. Brown; Evan R. Simpson
Editorial: Springer (2013)
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos Tapa blanda Cantidad: 1
Librería
Valoración
[?]

Descripción Springer, 2013. Estado de conservación: New. Nº de ref. de la librería L9781489980014

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 77,00
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 2,99
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

10.

Kristy A. Brown
Editorial: Springer-Verlag Gmbh Nov 2013 (2013)
ISBN 10: 1489980016 ISBN 13: 9781489980014
Nuevos Taschenbuch Cantidad: 1
Librería
Valoración
[?]

Descripción Springer-Verlag Gmbh Nov 2013, 2013. Taschenbuch. Estado de conservación: Neu. Neuware - Obesity is a risk factor for breast cancer in older women. A number of adipose-derived and obesity-related factors have been shown to affect tumour cell growth. These include adipokines, insulin, IGF-1 and oestrogens. The majority of obesity-related postmenopausal breast cancers are oestrogen-dependent. Since the ovaries no longer produce oestrogens after menopause, and that circulating levels are negligible, it is evident that it is the oestrogens produced locally within the breast adipose that are responsible for the increased growth of breast cancer cells. Aromatase is the enzyme that converts androgens into oestrogens and its regulation is dependent on the activity of a number of tissue-specific promoters. Targeting oestrogen biosynthesis in obesity may be useful for the prevention of breast cancer. Aromatase inhibitors are efficacious at treating postmenopausal breast cancer and recent studies suggest that they may also be useful in the prevention setting. However, these compounds inhibit the catalytic activity of aromatase and as a consequence lead to a number of undesirable side-effects, including arthralgia and possible cognitive defects due to inhibition of aromatase in the bone and brain, respectively. Novel therapies, such as those employed to treat obesity-associated disease, including anti-diabetics, may prove successful at inhibiting aromatase specifically within the breast. This SpringerBrief will explore all of these issues in depth and the authors are in a unique position to write about this topic, having extensive experience in the field of aromatase research. 56 pp. Englisch. Nº de ref. de la librería 9781489980014

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 69,99
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 12,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Existen otras copia(s) de este libro

Ver todos los resultados de su búsqueda